Christopher Primiano | SVP, Operations & Business Development, General Counsel and Secretary |
Michael Kauffman | CEO |
Michael Falvey | CFO |
Jatin Shah | VP, Clinical Strategy |
Maury Raycroft | Jefferies |
Jonathan Chang | Leerink Swann |
Eric Joseph | JPMorgan |
Mike King | JMP Securities |
Ying Huang | Bank of America Merrill Lynch |
Good morning. My name is Iola [ph] and I will be your conference operator today. At this time, I will like to welcome everyone to the Karyopharm Therapeutics First Quarter and 2018 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.